Annual Total Assets
$99.82 B
-$4.93 B-4.71%
31 March 2024
Summary:
Takeda Pharmaceutical Company Limited annual total assets is currently $99.82 billion, with the most recent change of -$4.93 billion (-4.71%) on 31 March 2024. During the last 3 years, it has fallen by -$17.23 billion (-14.72%). TAK annual total assets is now -19.75% below its all-time high of $124.40 billion, reached on 31 March 2019.TAK Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$102.04 B
+$1.20 B+1.19%
01 September 2024
Summary:
Takeda Pharmaceutical Company Limited quarterly total assets is currently $102.04 billion, with the most recent change of +$1.20 billion (+1.19%) on 01 September 2024. Over the past year, it has increased by +$2.49 billion (+2.50%). TAK quarterly total assets is now -18.75% below its all-time high of $125.59 billion, reached on 30 June 2019.TAK Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.7% | +2.5% |
| 3 y3 years | -14.7% | -9.1% |
| 5 y5 years | -19.8% | -14.5% |
TAK Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.7% | at low | -9.1% | +2.5% |
| 5 y | 5 years | -19.8% | at low | -14.7% | +2.5% |
| alltime | all time | -19.8% | +620.2% | -18.8% | +266.0% |
Takeda Pharmaceutical Company Limited Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $102.04 B(+1.2%) |
| June 2024 | - | $100.84 B(+1.0%) |
| Mar 2024 | $99.82 B(-4.7%) | $99.82 B(-1.0%) |
| Dec 2023 | - | $100.85 B(+1.3%) |
| Sept 2023 | - | $99.55 B(-2.6%) |
| June 2023 | - | $102.16 B(-2.5%) |
| Mar 2023 | $104.75 B(-3.0%) | $104.75 B(+1.7%) |
| Dec 2022 | - | $103.00 B(+2.0%) |
| Sept 2022 | - | $100.98 B(-1.9%) |
| June 2022 | - | $102.97 B(-4.6%) |
| Mar 2022 | $107.97 B(-7.8%) | $107.97 B(-2.2%) |
| Dec 2021 | - | $110.35 B(-1.6%) |
| Sept 2021 | - | $112.20 B(-2.0%) |
| June 2021 | - | $114.50 B(-2.2%) |
| Mar 2021 | $117.05 B(-1.3%) | $117.05 B(-1.7%) |
| Dec 2020 | - | $119.13 B(+1.4%) |
| Sept 2020 | - | $117.48 B(+0.2%) |
| June 2020 | - | $117.23 B(-1.2%) |
| Mar 2020 | $118.63 B(-4.6%) | $118.63 B(-0.9%) |
| Dec 2019 | - | $119.67 B(+0.3%) |
| Sept 2019 | - | $119.31 B(-5.0%) |
| June 2019 | - | $125.59 B(+1.0%) |
| Mar 2019 | $124.40 B(+221.9%) | $124.40 B(+138.0%) |
| Dec 2018 | - | $52.26 B(+39.0%) |
| Sept 2018 | - | $37.60 B(-0.1%) |
| June 2018 | - | $37.64 B(-2.6%) |
| Mar 2018 | $38.64 B(-0.6%) | $38.64 B(-1.2%) |
| Dec 2017 | - | $39.12 B(+0.6%) |
| Sept 2017 | - | $38.90 B(+0.3%) |
| June 2017 | - | $38.79 B(-0.2%) |
| Mar 2017 | $38.88 B(+14.3%) | $38.88 B(+9.2%) |
| Dec 2016 | - | $35.61 B(-5.2%) |
| Sept 2016 | - | $37.56 B(+1.2%) |
| June 2016 | - | $37.13 B(+9.1%) |
| Mar 2016 | $34.02 B | $34.02 B(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | $34.78 B(-1.1%) |
| Sept 2015 | - | $35.15 B(-0.2%) |
| June 2015 | - | $35.21 B(-1.6%) |
| Mar 2015 | $35.79 B(-19.4%) | $35.79 B(-8.1%) |
| Dec 2014 | - | $38.95 B(-6.8%) |
| Sept 2014 | - | $41.79 B(-4.5%) |
| June 2014 | - | $43.75 B(-1.5%) |
| Mar 2014 | $44.40 B(+3.2%) | $44.40 B(+5.3%) |
| Dec 2013 | - | $42.18 B(-3.0%) |
| Sept 2013 | - | $43.47 B(+8.8%) |
| June 2013 | - | $39.94 B(-7.2%) |
| Mar 2013 | $43.04 B(-1.8%) | $43.04 B(-2.2%) |
| Dec 2012 | - | $44.00 B(-1.9%) |
| Sept 2012 | - | $44.85 B(+2.6%) |
| June 2012 | - | $43.70 B(-0.3%) |
| Mar 2012 | $43.82 B(+30.8%) | $43.82 B(-0.5%) |
| Dec 2011 | - | $44.03 B(-3.4%) |
| Sept 2011 | - | $45.60 B(+35.6%) |
| June 2011 | - | $33.62 B(+0.4%) |
| Mar 2011 | $33.49 B(+11.0%) | $33.49 B(+1.8%) |
| Dec 2010 | - | $32.88 B(+1.8%) |
| Sept 2010 | - | $32.31 B(+6.5%) |
| June 2010 | - | $30.33 B(+0.5%) |
| Mar 2010 | $30.18 B(+8.3%) | $30.18 B(+2.0%) |
| Dec 2009 | - | $29.60 B(-2.9%) |
| Sept 2009 | - | $30.47 B(+9.3%) |
| Mar 2009 | $27.88 B(-2.3%) | $27.88 B(-1.0%) |
| Dec 2008 | - | $28.15 B |
| Mar 2008 | $28.52 B(+9.5%) | - |
| Mar 2007 | $26.05 B(+0.9%) | - |
| Mar 2006 | $25.83 B(+8.8%) | - |
| Mar 2005 | $23.75 B(+6.0%) | - |
| Mar 2004 | $22.41 B(+28.4%) | - |
| Mar 2003 | $17.45 B(+18.0%) | - |
| Mar 2002 | $14.79 B(+6.7%) | - |
| Mar 2001 | $13.86 B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total assets?
- What is the all time high annual total assets for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual total assets year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total assets?
- What is the all time high quarterly total assets for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly total assets year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total assets?
The current annual total assets of TAK is $99.82 B
What is the all time high annual total assets for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total assets is $124.40 B
What is Takeda Pharmaceutical Company Limited annual total assets year-on-year change?
Over the past year, TAK annual total assets has changed by -$4.93 B (-4.71%)
What is Takeda Pharmaceutical Company Limited quarterly total assets?
The current quarterly total assets of TAK is $102.04 B
What is the all time high quarterly total assets for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total assets is $125.59 B
What is Takeda Pharmaceutical Company Limited quarterly total assets year-on-year change?
Over the past year, TAK quarterly total assets has changed by +$2.49 B (+2.50%)